Skip to content
Research/Anti Inflammatory/N-Acetyl-Cysteine

N-Acetyl-Cysteine

N-Acetyl-Cysteine (NAC) is a precursor to the antioxidant glutathione, which helps reduce oxidative stress and inflammation in the body. It is used to support liver detoxification, respiratory health, and has potential benefits for mental health conditions. Its role in reducing oxidative damage makes it relevant for longevity and health optimization.

Intelligence Profile

Research Papers

Research on N-Acetyl-Cysteine (NAC) spans various areas, investigating its potential therapeutic benefits in multiple conditions.

A study published in "Free Radical Biology & Medicine" explored NAC's role in regulating the endoplasmic reticulum stress response in chondrocytes exposed to proinflammatory cytokines, suggesting NAC may help manage cellular stress in inflammatory conditions (PMID: 42551764).

NAC has also been studied for its ability to restore mitochondrial homeostasis by counteracting oxidative stress and fusion-fission imbalances in lipotoxicity models, as indicated in "Journal of Oleo Science" (PMID: 42543617). This highlights its potential in conditions associated with oxidative stress.

In "Experimental Gerontology," research highlighted NAC's potential to counteract cellular senescence via the HuR pathway in endothelial cells, suggesting a possible role in aging and vascular health (PMID: 42537761).

Another study in "Tissue & Cell" found NAC beneficial in protecting against myocardial injury by activating Nrf2/HO-1 signaling pathways, which may aid in managing heart-related conditions (PMID: 42537248).

Clinical trials further explore NAC's wide-ranging uses. A completed Phase 1/2 pilot study examined NAC in patients with sickle cell disease, though detailed outcomes are not specified (NCT01800526). Another completed study focused on NAC's bioavailability in healthy subjects, serving as a foundation for its use in various interventions (NCT05041179).

Despite these promising studies, other trials have faced challenges or were terminated, such as those exploring NAC for steroid-resistant acute GvHD and COPD, underscoring the need for further research to clarify its efficacy and safety profiles (NCT02411084, NCT01739790).

This synthesis demonstrates NAC's diverse potential but also indicates an ongoing need for comprehensive research to solidify its clinical applications.

Disclaimer: This information is for educational purposes only and not a substitute for professional medical advice. Always consult healthcare providers for treatment guidance.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.